CHICAGO, May 13, 2019 /PRNewswire/ — The Chartis Group has been named to Modern Healthcare’s Best Places to Work in Healthcare for 2019. The complete list of this year’s winners, in alphabetical order is here.
In a statement Modern Healthcare noted, “Organizations making this year’s list of Best Places to Work in Healthcare stand out in their efforts to create an empowered and satisfied workforce. They did so by nurturing a sense of loyalty and building engagement.”
“We are honored to once again be named as one of Modern Healthcare’s Best Places to Work in Healthcare,” stated Shannon Brownell, Chief Talent Officer of The Chartis Group.
“Our mission to materially impact the delivery of healthcare has never been more critical or more meaningful for the highly talented colleagues who make Chartis such a unique place to work. Moreover, our growth has only amplified the warm, collegial culture that distinguishes us as a firm.”
Modern Healthcare will announce the ranked order at an awards gala on September 26, 2019 in Dallas following Modern Healthcare’s Workplace of the Future Conference.
About The Chartis Group
The Chartis Group® (Chartis) provides comprehensive advisory services and analytics to the healthcare industry. With an unparalleled depth of expertise in strategic planning, performance excellence, informatics and technology, and health analytics, Chartis helps leading academic medical centers, integrated delivery networks, children’s hospitals and healthcare service organizations achieve transformative results. Chartis has offices in Atlanta, Boston, Chicago, New York, Minneapolis and San Francisco. For more information, visit www.chartis.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/the-chartis-group-selected-as-one-of-modern-healthcares-best-places-to-work-in-healthcare-for-2019-300849176.html
SOURCE The Chartis Group
SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare…
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had…
Pemvidutide elicited significant weight loss and decreases in pro-inflammatory serum lipids associated with atherogenesis and…
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…